Aimei Health Technology Co., Ltd.

Aimei Health Technology Co., Ltd. (Nasdaq: AFJK) is a blank check company formed to pursue an acquisition target in the healthcare and health technology sector. The company, which completed its initial public offering in 2024, filed a Form 10-Q with the SEC on November 18, 2025, reflecting its continued status as an active reporting SPAC. AFJK is focused on identifying a merger candidate within the health technology industry, a space that has attracted sustained SPAC sponsor interest in recent years. The filing provides a quarterly snapshot of the company's financial position as it progresses through its deal search. Visit SpacDesk and sign up for full data, filings, and deal-flow analytics on AFJK and hundreds of other active SPACs.